Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2017 (2017), Article ID 4093171, 8 pages
https://doi.org/10.1155/2017/4093171
Research Article

Clinical Utility of Urinary β2-Microglobulin in Detection of Early Nephropathy in African Diabetes Mellitus Patients

1University of Uyo and University of Uyo Teaching Hospital, Uyo, Nigeria
2University of Calabar, Calabar, Nigeria
3University College Hospital, Ibadan, Nigeria

Correspondence should be addressed to U. E. Ekrikpo; gn.ude.oyuinu@opkirkeemedu

Received 31 July 2016; Revised 18 December 2016; Accepted 4 January 2017; Published 30 January 2017

Academic Editor: Franca Anglani

Copyright © 2017 U. E. Ekrikpo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Shaheen and A. Al-Khader, “Epidemiology and causes of end stage renal disease (ESRD),” Saudi Journal of Kidney Diseases and Transplantation, vol. 16, pp. 277–281, 2005. View at Google Scholar
  2. P. C. W. Van Dijk, K. J. Jager, B. Stengel, C. Grönhagen-Riska, T. G. Feest, and J. D. Briggs, “Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991–2000),” Kidney International, vol. 67, no. 4, pp. 1489–1499, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. M. E. Williams, “Diabetic CKD/ESRD 2010: a progress report?” Seminars in Dialysis, vol. 23, no. 2, pp. 129–133, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. U.S. Renal Data System UADR, Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md, USA, 2008.
  5. C. E. Lok, M. J. Oliver, D. M. Rothwell, and J. E. Hux, “The growing volume of diabetes-related dialysis: a population based study,” Nephrology Dialysis Transplantation, vol. 19, no. 12, pp. 3098–3103, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Iseki, “Chronic kidney disease in Japan,” Internal Medicine, vol. 47, no. 8, pp. 681–689, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. É. Counil, N. Cherni, M. Kharrat, A. Achour, and H. Trimech, “Trends of incident dialysis patients in Tunisia between 1992 and 2001,” American Journal of Kidney Diseases, vol. 51, no. 3, pp. 463–470, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. E. K. Sumaili, E. P. Cohen, C. V. Zinga, J.-M. Krzesinski, N. M. Pakasa, and N. M. Nseka, “High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo,” BMC Nephrology, vol. 10, no. 1, article 18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. O. R. Adetunji, J. O. Adeleye, N. O. Agada, and B. L. Salako, “Microalbuminuria and clinical correlates in black African patients with type 2 diabetes,” West African Journal of Medicine, vol. 25, no. 4, pp. 279–283, 2006. View at Google Scholar · View at Scopus
  10. C. O. Alebiosu, “Clinical diabetic nephropathy in a tropical African population,” West African Journal of Medicine, vol. 22, no. 2, pp. 152–155, 2003. View at Google Scholar · View at Scopus
  11. C. O. Alebiosu, O. O. Ayodele, A. Abbas, and I. A. Olutoyin, “Chronic renal failure at the Olabisi Onabanjo university teaching hospital, Sagamu, Nigeria,” African Health Sciences, vol. 6, no. 3, pp. 132–138, 2006. View at Google Scholar · View at Scopus
  12. A. R. Omran, “The epidemiologic transition: a theory of the epidemiology of population change,” Milbank Quarterly, vol. 83, no. 4, pp. 731–757, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Unwin, F. Mugusi, T. Aspray et al., “Tackling the emerging pandemic of non-communicable diseases in sub-Saharan Africa: the essential NCD health intervention project,” Public Health, vol. 113, no. 3, pp. 141–146, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. E. E. Owoaje, C. N. Rotimi, J. S. Kaufman, J. Tracy, and R. S. Cooper, “Prevalence of adult diabetes in Ibadan, Nigeria,” East African Medical Journal, vol. 74, no. 5, pp. 299–302, 1997. View at Google Scholar · View at Scopus
  15. E. A. Nyenwe, O. J. Odia, A. E. Ihekwaba, A. Ojule, and S. Babatunde, “Type 2 diabetes in adult Nigerians: a study of its prevalence and risk factors in Port Harcourt, Nigeria,” Diabetes Research and Clinical Practice, vol. 62, no. 3, pp. 177–185, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. C. O. Alebiosu and O. E. Ayodele, “The increasing prevalence of diabetic nephropathy as a cause of end stage renal disease in Nigeria,” Tropical Doctor, vol. 36, no. 4, pp. 218–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Afifi, M. El Setouhy, M. El Sharkawy et al., “Diabetic nephropathy as a cause of end-stage renal disease in Egypt: a six-year study,” Eastern Mediterranean Health Journal, vol. 10, no. 4-5, pp. 620–626, 2004. View at Google Scholar
  18. R. Star, T. Hostetter, and G. L. Hortin, “New markers for kidney disease,” Clinical Chemistry, vol. 48, no. 9, pp. 1375–1376, 2002. View at Google Scholar · View at Scopus
  19. J. L. Gross, M. J. De Azevedo, S. P. Silveiro, L. H. Canani, M. L. Caramori, and T. Zelmanovitz, “Diabetic nephropathy: diagnosis, prevention, and treatment,” Diabetes Care, vol. 28, no. 1, pp. 164–176, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. F. N. Ziyadeh and S. Goldfarb, “The renal tubulointerstitium in diabetes mellitus,” Kidney International, vol. 39, no. 3, pp. 464–475, 1991. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Tojo, M. Onozato, H. Ha et al., “Reduced albumin reabsorption in the proximal tubule of early-stage diabetic rats,” Histochemistry and Cell Biology, vol. 116, no. 3, pp. 269–276, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Kunika, T. Yamaoka, and M. Itakura, “Damage of charge-dependent renal tubular reabsorption causes diabetic microproteinuria,” Diabetes Research and Clinical Practice, vol. 36, no. 1, pp. 1–9, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Ginevri, E. Piccotti, R. Alinovi et al., “Reversible tubular proteinuria precedes microalbuminuria and correlates with the metabolic status in diabetic children,” Pediatric Nephrology, vol. 7, no. 1, pp. 23–26, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. F. P. Udomah, U. E. Ekrikpo, E. Effa, B. Salako, A. Arije, and S. Kadiri, “Association between urinary N-acetyl-beta-D-glucosaminidase and microalbuminuria in diabetic black Africans,” International Journal of Nephrology, vol. 2012, Article ID 235234, 5 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Floege and M. Ketteler, “β2-microglobulin-derived amyloidosis: an update,” Kidney International, Supplement, vol. 59, no. 78, pp. S164–S171, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. L. W. S. Van Eps and G. H. C. Schardijn, “Value of determination of β2-microglobulin in toxic nephropathy and interstitial nephritis,” Wiener Klinische Wochenschrift, vol. 96, no. 18, pp. 673–678, 1984. View at Google Scholar · View at Scopus
  27. B. Hofmann, Y. X. Wang, W. G. Cumberland, R. Detels, M. Bozorgmehri, and J. L. Fahey, “Serum beta2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis,” AIDS, vol. 4, no. 3, pp. 207–214, 1990. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Henne, P. Frei, and P. Bürgisser, “Beta-2-microglobulin—a rapid and automated determination for a broad range of clinical applications,” Anticancer Research, vol. 17, no. 4, pp. 2915–2918, 1997. View at Google Scholar · View at Scopus
  29. D. W. Cockcroft and M. H. Gault, “Prediction of creatinine clearance from serum creatinine,” Nephron, vol. 16, no. 1, pp. 31–41, 1976. View at Publisher · View at Google Scholar · View at Scopus
  30. A. S. Levey, J. Coresh, T. Greene et al., “Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values,” Clinical Chemistry, vol. 53, no. 4, pp. 766–772, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. A. S. Levey, L. A. Stevens, C. H. Schmid et al., “A new equation to estimate glomerular filtration rate,” Annals of Internal Medicine, vol. 150, no. 9, pp. 604–612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  33. O. Kordonouri, R. Hartmann, C. Müller, T. Danne, and B. Weber, “Predictive value of tubular markers for the development of microalbuminuria in adolescents with diabetes,” Hormone Research, vol. 50, supplement 1, pp. 23–27, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Apakkan Aksun, D. Özmen, B. Özmen et al., “β2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy,” Experimental and Clinical Endocrinology and Diabetes, vol. 112, no. 4, pp. 195–200, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Tanaka, K. Shima, M. Fukuda, Y. Tahara, Y. Yamamoto, and Y. Kumahara, “Tubular dysfunction in the early stage of diabetic nephropathy,” Medical Journal of Osaka University, vol. 38, no. 1-4, pp. 57–63, 1989. View at Google Scholar · View at Scopus
  36. J. Dauzat, S. Moinade, and G. Gaillard, “Beta 2 microglobulin in diabetic patients. Apropos of 190 subjects,” La Semaine des Hopitaux, vol. 60, no. 11, pp. 745–748, 1984. View at Google Scholar
  37. A. Khedr, E. Khedr, and A. A. House, “Body mass index and the risk of progression of chronic kidney disease,” Journal of Renal Nutrition, vol. 21, no. 6, pp. 455–461, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. C. Thomas, W. C. Burns, and M. E. Cooper, “Tubular changes in early diabetic nephropathy,” Advances in Chronic Kidney Disease, vol. 12, no. 2, pp. 177–186, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. C. J. Magri and S. Fava, “The role of tubular injury in diabetic nephropathy,” European Journal of Internal Medicine, vol. 20, no. 6, pp. 551–555, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. L. M. Russo, R. M. Sandoval, S. B. Campos, B. A. Molitoris, W. D. Comper, and D. Brown, “Impaired tubular uptake explains albuminuria in early diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 20, no. 3, pp. 489–494, 2009. View at Publisher · View at Google Scholar · View at Scopus